Claritev Corporation

Healthcare

NYSE:CTEV · New York Stock Exchange

Market Cap $507.17M Beta 0.77 P/E (TTM) -1.8

$29.42 +1.41%

+$0.42 today

52W Low $11.50High $74.07

Vol 0.18M · Avg 0.14M

EPS (TTM) -$17.16Medical - Healthcare Information Services

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-29.09%

Period High

$72.58

Period Low

$13.47

Latest

$29.42

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Dianthus Therapeutics, Inc.

NASDAQ:DNTH

$3.37B

AxoGen, Inc.

NASDAQ:AXGN

$2.39B

Integra LifeSciences Holdings Corporation

NASDAQ:IART

$1.38B

IRadimed Corporation

NASDAQ:IRMD

$1.18B

OPKO Health, Inc.

NASDAQ:OPK

$1.08B

GoodRx Holdings, Inc.

NASDAQ:GDRX

$920.30M

Sana Biotechnology, Inc.

NASDAQ:SANA

$855.75M

InMode Ltd.

NASDAQ:INMD

$814.53M

Evolent Health, Inc.

NYSE:EVH

$494.35M

LifeMD, Inc.

NASDAQ:LFMD

$229.96M

What is the latest CTEV filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does CTEV have?

Intrinsic Alpha currently shows 20 recent filings for CTEV.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.